|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 213.4 USD | +16.37% |
|
+18.50% | +23.20% |
| 05:37pm | KeyBanc Adjusts Price Target on ResMed to $238 From $227 | MT |
| 05:04pm | ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17% | MT |
ResMed Inc.(NYSE:RMD) dropped from Russell Midcap Value Index
| 1st Jan change | Capi. | |
|---|---|---|
| +23.20% | 26.94B | |
| +8.00% | 218B | |
| +6.84% | 182B | |
| +11.11% | 132B | |
| +26.58% | 108B | |
| +14.31% | 52.98B | |
| -1.89% | 47.59B | |
| -0.61% | 39.96B | |
| +10.91% | 39.22B | |
| -11.48% | 19.28B |
RESMED, INC. 
